Tag Archives: Mouse monoclonal to CD15.DW3 reacts with CD15 3-FAL )

Background Hepatic resection is currently still the best choice of therapeutic

Background Hepatic resection is currently still the best choice of therapeutic strategies for liver cancer, but the long-term survival rate after surgery is unsatisfactory. After the completion of surgical intervention, patients will be included in a 3-year follow-up program. Discussion … Continue reading

Posted in Main | Tagged , , , , , | Comments Off on Background Hepatic resection is currently still the best choice of therapeutic